2026-2034年全球心律不整治療設備市場規模、佔有率、趨勢與成長分析報告

心律不整治療設備的市場規模預計將從 2025 年的 90.1 億美元成長到 2034 年的 177 億美元，2026 年至 2034 年的複合年成長率為 7.79%。

全球心血管疾病盛行率的不斷上升正顯著推動全球心律不整治療設備市場的成長。心律不整是指不規則的心率，若不及時治療，可能導致嚴重的健康併發症。心臟節律器、植入式心臟整流去顫器（ICD）和心導管電氣燒灼術系統等醫療設備被廣泛用於管理和治療這些疾病。人們對心臟健康的日益重視以及先進治療技術的廣泛應用，都為市場成長提供了支持。

推動這一市場發展的主要因素是全球人口老化，老年人更容易患心血管疾病，包括心律不整。久坐不動的生活方式、不健康的飲食習慣以及高血壓和糖尿病盛行率的上升也加劇了心率的發生。此外，心臟監測和微創手術技術的進步改善了治療效果，並推動了心律不整治療設備的普及應用。

鑑於醫療專業人員持續採用創新心臟護理技術，該市場的未來前景依然十分光明。心律不整治療設備的有效性正透過設備設計、遠端監測功能和電池壽命的不斷改進而日益提高。隨著新興國家對心血管研究投入的增加和醫療基礎設施的不斷完善，心律不整治療設備市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球心律不整治療設備市場：依類型分類

• 市場分析、洞察與預測
• 心電圖監測儀
• 植入式監測器
• 心電圖監測
• 移動心電遙測

第5章：全球心律不整治療設備市場：依應用領域分類

• 市場分析、洞察與預測
• 心搏過緩
• 心搏過速
• 心房顫動
• 心室顫動
• 早搏
• 其他

第6章 全球心律不整治療設備市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 門診部
• 診斷中心
• 其他

第7章 全球心律不整治療設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • ACS Diagnostics
  • GE HealthCare
  • Biotronik
  • IRhythm Technologies Inc
  • Medtronic
  • Koninklijke Philips NV
  • Fukuda Denshi
  • Spacelabs Healthcare
  • AliveCor Inc

The Arrhythmia Treatment Devices Market size is expected to reach USD 17.70 Billion in 2034 from USD 9.01 Billion (2025) growing at a CAGR of 7.79% during 2026-2034.

The global arrhythmia treatment devices market is experiencing significant growth due to the rising prevalence of cardiovascular diseases worldwide. Arrhythmia refers to irregular heart rhythms that can lead to serious health complications if left untreated. Medical devices such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac ablation systems are widely used to manage and treat these conditions. Increasing awareness about heart health and the availability of advanced treatment technologies are supporting market growth.

A key driver of this market is the aging global population, which is more susceptible to cardiovascular disorders including arrhythmia. Sedentary lifestyles, unhealthy dietary habits, and rising cases of hypertension and diabetes are also contributing to the increasing number of heart rhythm disorders. Additionally, technological advancements in cardiac monitoring and minimally invasive procedures are improving treatment outcomes and encouraging greater adoption of arrhythmia treatment devices.

The future outlook for this market remains highly promising as healthcare providers continue to adopt innovative cardiac care technologies. Continuous improvements in device design, remote monitoring capabilities, and battery life are enhancing the effectiveness of arrhythmia treatment devices. With increasing investments in cardiovascular research and growing healthcare infrastructure in emerging economies, the arrhythmia treatment devices market is expected to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• ECG Monitors
• Implantable Monitors
• Holter Monitors
• Mobile Cardiac Telemetry

By Application

• Bradycardia
• Tachycardia
• Atrial Fibrillation
• Ventricular Fibrillation
• Premature Contraction
• Others

By End-Use

• Hospitals and Clinics
• Ambulatory Centers
• Diagnostic Centers
• Others

COMPANIES PROFILED

• Abbott, ACS Diagnostics, GE HealthCare, Biotronik, iRhythm Technologies Inc, Medtronic, Koninklijke Philips NV, Fukuda Denshi, Spacelabs Healthcare, AliveCor Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARRHYTHMIA TREATMENT DEVICES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. ECG Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Implantable Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Holter Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Mobile Cardiac Telemetry Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARRHYTHMIA TREATMENT DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Bradycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tachycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Atrial Fibrillation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Ventricular Fibrillation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Premature Contraction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARRHYTHMIA TREATMENT DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARRHYTHMIA TREATMENT DEVICES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ARRHYTHMIA TREATMENT DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 ACS Diagnostics
  • 9.2.3 GE HealthCare
  • 9.2.4 Biotronik
  • 9.2.5 IRhythm Technologies Inc
  • 9.2.6 Medtronic
  • 9.2.7 Koninklijke Philips N.V
  • 9.2.8 Fukuda Denshi
  • 9.2.9 Spacelabs Healthcare
  • 9.2.10 AliveCor Inc